Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia-Reference-Cited by-同舟云学术

Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia

Published:2020-06-26 Issue:12 Volume:34 Page:3359-3369
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Liu Limin,Zhang Yanming,Jiao Wenjing,Zhou Huifen,Wang Qingyuan,Jin Song,Cai Yifeng,Zhao Liyun,Shangguan Xiaohui,Liu Zefa,Xu Jinge,Lei Meiqing,Yan Xiaoyun,Miao Miao,Wu Depei^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0933-7.pdf

Reference52 articles.

1. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002;136:534–46.

2. Kosaka Y, Yagasaki H, Sano K, Kobayashi R, Ayukawa H, Kaneko T, et al. Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia. Blood. 2008;111:1054–9.

3. Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129:1428–36.

4. Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187–207.

5. Wu Y, Cao Y, Li X, Xu L, Wang Z, Liu P, et al. Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells for severe aplastic anemia: successful engraftment andmild GVHD. Stem Cell Res. 2014;12:132–8.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A latent profile analysis of health-related quality of life in patients with aplastic anemia;2024-08-09

2. Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence;Annals of Hematology;2024-08-01

3. First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study;Bone Marrow Transplantation;2024-08-01

4. Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation Cyclophosphamide;Transplantation and Cellular Therapy;2024-05

5. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study;Frontiers in Immunology;2024-04-24